Literature DB >> 20972335

Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis.

Goutam Ghosh1, Indira V Subramanian, Neeta Adhikari, Xiaoxiao Zhang, Hemant P Joshi, David Basi, Y S Chandrashekhar, Jennifer L Hall, Sabita Roy, Yan Zeng, Sundaram Ramakrishnan.   

Abstract

Adaptive changes to oxygen availability are critical for cell survival and tissue homeostasis. Prolonged oxygen deprivation due to reduced blood flow to cardiac or peripheral tissues can lead to myocardial infarction and peripheral vascular disease, respectively. Mammalian cells respond to hypoxia by modulating oxygen-sensing transducers that stabilize the transcription factor hypoxia-inducible factor 1α (HIF-1α), which transactivates genes governing angiogenesis and metabolic pathways. Oxygen-dependent changes in HIF-1α levels are regulated by proline hydroxylation and proteasomal degradation. Here we provide evidence for what we believe is a novel mechanism regulating HIF-1α levels in isolated human ECs during hypoxia. Hypoxia differentially increased microRNA-424 (miR-424) levels in ECs. miR-424 targeted cullin 2 (CUL2), a scaffolding protein critical to the assembly of the ubiquitin ligase system, thereby stabilizing HIF-α isoforms. Hypoxia-induced miR-424 was regulated by PU.1-dependent transactivation. PU.1 levels were increased in hypoxic endothelium by RUNX-1 and C/EBPα. Furthermore, miR-424 promoted angiogenesis in vitro and in mice, which was blocked by a specific morpholino. The rodent homolog of human miR-424, mu-miR-322, was significantly upregulated in parallel with HIF-1α in experimental models of ischemia. These results suggest that miR-322/424 plays an important physiological role in post-ischemic vascular remodeling and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972335      PMCID: PMC2964978          DOI: 10.1172/JCI42980

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  74 in total

Review 1.  MicroRNAs and cancer.

Authors:  T Dalmay
Journal:  J Intern Med       Date:  2008-02-20       Impact factor: 8.989

2.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

3.  Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density.

Authors:  R Wild; S Ramakrishnan; J Sedgewick; A W Griffioen
Journal:  Microvasc Res       Date:  2000-05       Impact factor: 3.514

4.  PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.

Authors:  Gang Huang; Pu Zhang; Hideyo Hirai; Shannon Elf; Xiaomei Yan; Zhao Chen; Steffen Koschmieder; Yutaka Okuno; Tajhal Dayaram; Joseph D Growney; Ramesh A Shivdasani; D Gary Gilliland; Nancy A Speck; Stephen D Nimer; Daniel G Tenen
Journal:  Nat Genet       Date:  2007-11-11       Impact factor: 38.330

5.  Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  Stephen Kalscheuer; Xiaoxiao Zhang; Yan Zeng; Pramod Upadhyaya
Journal:  Carcinogenesis       Date:  2008-09-09       Impact factor: 4.944

6.  Hypoxia affects mesoderm and enhances hemangioblast specification during early development.

Authors:  Diana L Ramírez-Bergeron; Anja Runge; Karen D Cowden Dahl; Hans Joerg Fehling; Gordon Keller; M Celeste Simon
Journal:  Development       Date:  2004-09       Impact factor: 6.868

7.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

8.  Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia.

Authors:  Marta Bosch-Marce; Hiroaki Okuyama; Jacob B Wesley; Kakali Sarkar; Hideo Kimura; Ye V Liu; Huafeng Zhang; Marianne Strazza; Sergio Rey; Lindsey Savino; Yi Fu Zhou; Karin R McDonald; Youn Na; Scott Vandiver; Alireza Rabi; Yuval Shaked; Robert Kerbel; Theresa Lavallee; Gregg L Semenza
Journal:  Circ Res       Date:  2007-10-11       Impact factor: 17.367

9.  Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter.

Authors:  Michael J Chen; Tomomasa Yokomizo; Brandon M Zeigler; Elaine Dzierzak; Nancy A Speck
Journal:  Nature       Date:  2009-01-07       Impact factor: 49.962

10.  Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis.

Authors:  Coen van Solingen; Leonard Seghers; Roel Bijkerk; Jacques M G J Duijs; Marko K Roeten; Annemarie M van Oeveren-Rietdijk; Hans J Baelde; Matthieu Monge; Joost B Vos; Hetty C de Boer; Paul H A Quax; Ton J Rabelink; Anton Jan van Zonneveld
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.310

View more
  198 in total

1.  MicroRNA-322 protects hypoxia-induced apoptosis in cardiomyocytes via BDNF gene.

Authors:  Liguo Yang; Shigang Song; Hang Lv
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

Review 2.  Restoring the renal microvasculature to treat chronic kidney disease.

Authors:  David A Long; Jill T Norman; Leon G Fine
Journal:  Nat Rev Nephrol       Date:  2012-02-07       Impact factor: 28.314

3.  The cellular response to hypoxia: tuning the system with microRNAs.

Authors:  Joseph Loscalzo
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

4.  MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.

Authors:  Banumathy Gowrishankar; Ilsiya Ibragimova; Yan Zhou; Michael J Slifker; Karthik Devarajan; Tahseen Al-Saleem; Robert G Uzzo; Paul Cairns
Journal:  Cancer Biol Ther       Date:  2013-12-18       Impact factor: 4.742

5.  Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells.

Authors:  Alessandra Pincini; Giusy Tornillo; Francesca Orso; Marianna Sciortino; Brigitte Bisaro; Maria Del Pilar Camacho Leal; Antonio Lembo; Maria Felice Brizzi; Emilia Turco; Cristiano De Pittà; Paolo Provero; Enzo Medico; Paola Defilippi; Daniela Taverna; Sara Cabodi
Journal:  Cell Cycle       Date:  2013-06-28       Impact factor: 4.534

Review 6.  Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.

Authors:  Binod Aryal; Yajaira Suárez
Journal:  Vascul Pharmacol       Date:  2018-03-15       Impact factor: 5.773

Review 7.  MicroRNAs in endothelial cell homeostasis and vascular disease.

Authors:  Carlos Fernández-Hernando; Yajaira Suárez
Journal:  Curr Opin Hematol       Date:  2018-05       Impact factor: 3.284

Review 8.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

9.  Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis.

Authors:  Zhen Chen; Tsung-Ching Lai; Yi-Hua Jan; Feng-Mao Lin; Wei-Chi Wang; Han Xiao; Yun-Ting Wang; Wei Sun; Xiaopei Cui; Ying-Shiuan Li; Tzan Fang; Hongwei Zhao; Chellappan Padmanabhan; Ruobai Sun; Danny Ling Wang; Hailing Jin; Gar-Yang Chau; Hsien-Da Huang; Michael Hsiao; John Y-J Shyy
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

10.  Transforming growth factor β-regulated microRNA-29a promotes angiogenesis through targeting the phosphatase and tensin homolog in endothelium.

Authors:  Jun Wang; Youliang Wang; Yu Wang; Ying Ma; Yu Lan; Xiao Yang
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.